LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Microfluidic Disposable Device Diagnoses Diseases Cheaply

By LabMedica International staff writers
Posted on 16 Dec 2015
Image: Schematics of the reusable acoustic tweezers device (bottom) with a disposable microfluidic laboratory for cell manipulation and disease diagnosis (Photo courtesy of Penn State University).
Image: Schematics of the reusable acoustic tweezers device (bottom) with a disposable microfluidic laboratory for cell manipulation and disease diagnosis (Photo courtesy of Penn State University).
The development of a reusable microfluidic device for sorting and manipulating cells and other micro/nano meter scale objects will make biomedical diagnosis of diseases cheaper and more convenient in regions where medical facilities are sparse or cost is prohibitive.

Both bulk acoustic wave (BAW) and surface acoustic wave (SAW) based approaches have shown their competency in the manipulation of macro- to nano- scale objects, regardless of an object's optical or electrical properties. A wide range of applications in static or continuous flow such as manipulating cells, moving organisms have been demonstrated by either BAW or SAW tweezers.

Scientists at the Penn State University (University Park, PA, USA) developed reusable acoustic tweezers to realize acoustic manipulation of cells or particles with a SAW platform and disposable superstrate devices. They locally transmitted standing surface acoustic waves into a removable, independent polydimethylsiloxane (PDMS)-glass hybridized microfluidic superstrate device for micromanipulation. By configuring and regulating the displacement nodes on a piezoelectric substrate, cells and particles were effectively patterned and transported into the superstrate.

The label-free and contactless nature of acoustic waves could offer a simple, accurate, low-cost, biocompatible, and disposable method for applications in the fields of point-of-care diagnostics and fundamental biomedical studies. In addition to its use in diagnosing diseases such as human immunodeficiency virus (HIV) and tuberculosis, both of which are endemic in resource-poor regions of the world, the device should find widespread use in hospitals, clinics, biology laboratories and the home due to its low cost and ease of use.

Tony Jun Huang, PhD, a professor and lead author of the study, said, “We believe our acoustic tweezers have tremendous potential, especially in diagnostics, with some applications also in therapeutics. Our current device works well, but to be used in diagnostics, the whole device has to be disposed of after one use. We have now found a way to separate the fluid-containing part of the device from the much more expensive ultrasound-producing piezoelectric substrate. This makes disposable acoustic tweezers possible.” The study was published on October 28, 2015, in the journal Lab on a Chip.

Related Links:

Penn State University


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Automatic CLIA Analyzer
Shine i9000

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more